Procter & Gamble Health Limited (PGHL) - Total Assets

Latest as of September 2025: Rs8.94 Billion INR ≈ $96.73 Million USD

Based on the latest financial reports, Procter & Gamble Health Limited (PGHL) holds total assets worth Rs8.94 Billion INR (≈ $96.73 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Procter & Gamble Health Limited - Total Assets Trend (2003–2024)

This chart illustrates how Procter & Gamble Health Limited's total assets have evolved over time, based on quarterly financial data. Also see PGHL stock market capitalisation for the company's overall valuation and market capitalisation.

Procter & Gamble Health Limited - Asset Composition Analysis

Current Asset Composition (December 2024)

Procter & Gamble Health Limited's total assets of Rs8.94 Billion consist of 66.3% current assets and 33.7% non-current assets. Review PGHL liabilities breakdown to assess the company's total debt and financial obligations.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs898.10 Million	23.7%
Accounts Receivable	Rs1.47 Billion	18.5%
Inventory	Rs1.09 Billion	13.8%
Property, Plant & Equipment	Rs1.22 Billion	15.4%
Intangible Assets	Rs7.10 Million	0.1%
Goodwill	Rs0.00	0.0%

Asset Composition Trend (2003–2024)

This chart illustrates how Procter & Gamble Health Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See PGHL live share price for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Procter & Gamble Health Limited's current assets represent 66.3% of total assets in 2024, an increase from 48.6% in 2003.
Cash Position: Cash and equivalents constituted 23.7% of total assets in 2024, up from 0.3% in 2003.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2003.
Asset Diversification: The largest asset category is accounts receivable at 18.5% of total assets.

Procter & Gamble Health Limited Competitors by Total Assets

Key competitors of Procter & Gamble Health Limited based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Yunnan Baiyao Group Co Ltd SHE:000538	China	CN¥53.34 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	China	CN¥5.17 Billion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Harbin Gloria Pharmaceuticals SHE:002437	China	CN¥3.14 Billion
Jiuzhitang Co Ltd SHE:000989	China	CN¥5.73 Billion
Renhe Pharmacy Co Ltd SHE:000650	China	CN¥7.93 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion

Procter & Gamble Health Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.87	3.35	3.59
Quick Ratio	2.30	2.79	2.65
Cash Ratio	1.26	0.00	0.00
Working Capital	Rs4.17 Billion	Rs5.41 Billion	Rs4.24 Billion

Procter & Gamble Health Limited - Advanced Valuation Insights

This section examines the relationship between Procter & Gamble Health Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	14.25
Latest Market Cap to Assets Ratio	0.12
Asset Growth Rate (YoY)	0.0%
Total Assets	Rs7.94 Billion
Market Capitalization	$987.97 Million USD

Valuation Analysis

Below Book Valuation: The market values Procter & Gamble Health Limited's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Procter & Gamble Health Limited's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Procter & Gamble Health Limited (2003–2024)

The table below shows the annual total assets of Procter & Gamble Health Limited from 2003 to 2024.

Year	Total Assets	Change
2024-12-31	Rs7.94 Billion ≈ $85.89 Million	-0.02%
2023-12-31	Rs7.94 Billion ≈ $85.91 Million	-27.86%
2022-12-31	Rs11.01 Billion ≈ $119.09 Million	+23.21%
2021-12-31	Rs8.94 Billion ≈ $96.65 Million	-9.37%
2020-12-31	Rs9.86 Billion ≈ $106.65 Million	-16.17%
2019-12-31	Rs11.76 Billion ≈ $127.22 Million	-33.14%
2018-12-31	Rs17.59 Billion ≈ $190.28 Million	+77.50%
2017-12-31	Rs9.91 Billion ≈ $107.20 Million	+12.28%
2016-12-31	Rs8.83 Billion ≈ $95.47 Million	+12.61%
2015-12-31	Rs7.84 Billion ≈ $84.78 Million	+10.70%
2014-12-31	Rs7.08 Billion ≈ $76.59 Million	+9.19%
2013-12-31	Rs6.49 Billion ≈ $70.14 Million	+9.14%
2012-12-31	Rs5.94 Billion ≈ $64.27 Million	+18.94%
2011-12-31	Rs5.00 Billion ≈ $54.03 Million	+16.20%
2010-12-31	Rs4.30 Billion ≈ $46.50 Million	-24.32%
2009-12-31	Rs5.68 Billion ≈ $61.44 Million	+1.36%
2008-12-31	Rs5.61 Billion ≈ $60.62 Million	+14.50%
2007-12-31	Rs4.90 Billion ≈ $52.94 Million	+2.12%
2006-12-31	Rs4.79 Billion ≈ $51.84 Million	+23.73%
2005-12-31	Rs3.87 Billion ≈ $41.90 Million	+18.48%
2004-12-31	Rs3.27 Billion ≈ $35.36 Million	+17.60%
2003-12-31	Rs2.78 Billion ≈ $30.07 Million	--

About Procter & Gamble Health Limited

NSE:PGHL India Drug Manufacturers - Specialty & Generic

Market Cap

$987.97 Million

Rs91.35 Billion INR

Market Cap Rank

#9009 Global

#441 in India

Share Price

Rs5503.50

Change (1 day)

+1.27%

52-Week Range

Rs4778.60 - Rs6918.50

All Time High

Rs6918.50